Accro Grant Fosun Pharma Exclusive Rights for TYK2/JAK1 Inhibitor
29 Aug 2025 //
CONTRACTPHARMA
Accropeutics Reports Positive Phase 2 Data for AC-201 in Psoriasis
20 May 2025 //
PR NEWSWIRE
Blueprint Medicines Reports Q4 and Full Year 2024 Results
13 Feb 2025 //
PR NEWSWIRE